Biopharma Analysis Benefits from New Technology and Methods

被引:0
|
作者
Challener, Cynthia A.
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:10 / +
页数:5
相关论文
共 50 条
  • [12] OLD PART BENEFITS FROM NEW ROBOTIC WELDING TECHNOLOGY.
    Anon
    Welding Journal (Miami, Fla), 1986, 65 (11):
  • [13] Costs And Benefits Of Health Information Technology: New Trends From The Literature
    Goldzweig, Caroline Lubick
    Towfigh, Ali
    Maglione, Margaret
    Shekelle, Paul G.
    HEALTH AFFAIRS, 2009, 28 (02) : W282 - W293
  • [14] Assessing economic benefits from implementation of new pavement construction methods
    Gillen, D
    Harvey, J
    Cooper, D
    Hung, D
    TRANSPORTATION AND PUBLIC POLICY 2001: PLANNING AND ADMINISTRATION, 2001, (1747): : 71 - 78
  • [15] Assessing economic benefits from implementation of new pavement construction methods
    Gillen, David
    Harvey, John
    Cooper, Douglas
    Hung, David
    2001, National Research Council
  • [16] Spillover benefits from controlled nuclear fusion technology - A patent analysis
    Bruns, Peter
    Minh Quang Tran
    Kunz, Daniel
    Mueller, Heinz
    Soltmann, Christian
    WORLD PATENT INFORMATION, 2012, 34 (04) : 271 - 278
  • [17] CONFOCAL MICROSCOPY - CELL ANALYSIS BENEFITS FROM TECHNOLOGY-TRANSFER
    HIGGINS, TV
    LASER FOCUS WORLD, 1993, 29 (01): : 36 - 37
  • [18] Biopharma finds new world in Jupiter
    Philippidis A.
    Genetic Engineering and Biotechnology News, 2016, 36 (11): : 32
  • [19] Technology futures analysis: Toward integration of the field and new methods
    Porter, AL
    Ashton, WB
    Clar, G
    Coates, JF
    Cuhls, K
    Cunningham, SW
    Ducatel, K
    van der Duin, P
    Cunningham, SW
    Ducatel, K
    van der Duin, P
    Georghiou, L
    Gordon, T
    Linstone, H
    Marchau, V
    Massari, G
    Miles, I
    Mogee, M
    Salo, A
    Scapolo, F
    Smits, R
    Thissen, W
    TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2004, 71 (03) : 287 - 303
  • [20] Technology evaluation: AVI-4126, AVI BioPharma
    Stephens, AC
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2004, 6 (05) : 551 - 558